original ) (raw )Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1 ) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
Ramesh Babu Reddigunta
Journal of Medicinal Chemistry, 2021
View PDFchevron_right
A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
Chris Chapman
British Journal of Pharmacology, 2010
View PDFchevron_right
Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential
Erzsebet szabo
Journal of Lipid Research, 2019
View PDFchevron_right
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
Andrew Tager
Nature Medicine, 2008
View PDFchevron_right
Activity of 2-Substituted Lysophosphatidic Acid (LPA) Analogs at LPA Receptors: Discovery of a LPA1/LPA3 Receptor Antagonist
Kevin Lynch
2001
View PDFchevron_right
Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
K. Liliom
Molecular pharmacology, 1998
View PDFchevron_right
Lysophosphatidic Acid Induces Rapid and Sustained Decreases in Epidermal Growth Factor Receptor Binding via Different Signaling Pathways in BEAS-2B Airway Epithelial Cells
Myron Toews
Journal of Pharmacology and Experimental Therapeutics, 2008
View PDFchevron_right
Development of Our Current Understanding of Bioactive Lysophospholipids
Wouter Moolenaar
Annals of the New York Academy of Sciences, 2006
View PDFchevron_right
Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
Shaney Barratt
Clinical Pharmacology: Advances and Applications
View PDFchevron_right
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
Christophe Guignabert
Metabolites
View PDFchevron_right
A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis
Fabienne Briand-Mésange
Biochemical Journal, 2002
View PDFchevron_right
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
Fabio de Almeida Mendes
Signal Transduction and Targeted Therapy
View PDFchevron_right
Mechanisms of action of phospholipid analogs as anticancer compounds
Thomas Wieder
Progress in Lipid Research, 1999
View PDFchevron_right
Unfolding the Pathophysiological Role of Bioactive Lysophospholipids
Jerome Belinson
Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2003
View PDFchevron_right
Lysophosphatidic acid in airway function and disease
Myron Toews
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002
View PDFchevron_right
Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties
Timothy Cunningham
Journal of Inflammation, 2008
View PDFchevron_right
Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis
Gerard Mauco
FEBS Letters, 1997
View PDFchevron_right
Lysophosphatidic acid production and action: Validated targets in cancer?
Colin Ferguson
Journal of Cellular Biochemistry, 2004
View PDFchevron_right
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
Dagmar zu Heringdorf
Biochimica et Biophysica Acta (BBA) - Biomembranes, 2007
View PDFchevron_right
Lysophosphatidic acid signaling in airway epithelium: Role in airway inflammation and remodeling
Yutong Zhao
Cellular Signalling, 2009
View PDFchevron_right
Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model
Mauro Piantelli
Cancer, 2010
View PDFchevron_right
1,3‐Disubstituted‐4‐Aminopyrazolo [3, 4‐d] Pyrimidines, a New Class of Potent Inhibitors for Phospholipase D
Kimberly Stieglitz
Chemical Biology & Drug Design, 2014
View PDFchevron_right
In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone
Karl Y Hostetler
Biochimica et biophysica acta, 1988
View PDFchevron_right